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Medical Science
HIGH DIETARY SALT AND FRUCTOSE INCREASE NFAT5
EXPRESSION IN THE KIDNEY AND LIVER OF SPRAGUE
DAWLEY RATS. B. Herman1, K. Ferguson1, J. Halterman1, 2 & J.
Fernandez2, 1Dept. of Biology and 2MA in Biomedicine Program,
Eastern Mennonite University. In the current diet of an average
American, there is an increasing amount of both salt and high fructose
corn syrup. Individuals with a higher sensitivity to salt or fructose can
develop hypertension and metabolic syndrome. This study aimed to
determine how the consumption of a high salt diet or a high fructose
diet altered tissue-specific expression of the NFAT5 gene. A total of 50
Sprague Dawley rats were put either on a control diet of 0.25% NaCl
and 6% fructose, a 4% NaCl diet, 8% NaCl diet, or 64% fructose diet
over the course of 8 weeks. After 8 weeks, 16 different body tissue
samples were harvested. RNA was then purified from the samples,
reverse transcription was used to convert the purified RNA into DNA,
and DNA samples were then run under real-time PCR in order to
measure expression of the NFAT5 gene. The results showed an increase
in NFAT5 expression in the kidney medulla under a 4% NaCl diet and
in the kidney cortex under a 64% fructose diet. The results also
displayed an increase in NFAT5 expression in the liver under a 64%
fructose diet and 8% NaCl diet. From this study it can be concluded
that NFAT5 is differentially expressed in different tissues in response to
various diets. This study was funded by The Thomas F. and Kate
Miller Jeffress Memorial Trust, Bank of America, Trustee.
ROLE OF THE GASTROINTESTINAL MICROBIOME IN OPIOID
TOLERANCE. R.A. Mischel, M. Kang, W. Dewey, & H.I. Akbarali,
Dept. of Pharmacology & Toxicology, Virginia Commonwealth
University, Richmond, VA 23298. Gastrointestinal microbial dysbiosis
is known to alter physiologic homeostasis and contribute to
pathogenesis. Though morphine and other narcotics are the most
widely prescribed therapy for moderate to severe pain, they have been
noted to alter microbial composition and promote bacterial
translocation to other tissues. Translocated microbes may then
modulate local cell signaling and gene expression. One of the most
immediately vulnerable compartments following bacterial
dissemination is the intestinal wall, containing many terminal processes
of extrinsic primary afferent neurons (EPANs) from dorsal root ganglia
(DRG). These neurons play an integral role in analgesic tolerance, a
major limiting factor of clinical narcotic use. Despite this, the impact of
intestinal microbiota on the development of tolerance in these cells has
not been well characterized. To this end, we investigated how bacterial
depletion via broad-spectrum antibiotic treatment (ABX) impacts
nociceptive tolerance with chronic morphine use in mice. We found
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that ABX was effective in preventing tolerance in both the tailimmersion and acetic acid stretch assays of behavioral nociception.
These findings were recapitulated on a single-cell level in neurons
isolated from DRGs; namely, ABX prevented tolerance development to
morphine-induced reductions of excitability, as measured by increases
of threshold potential in whole-cell current clamp recordings. These
findings suggest that gastrointestinal flora play an important role in
modulating the pharmacodynamic properties of morphine in mice, and
may be a useful target of therapy in man.
C O R R E L AT I O N O F M O L E C U L A R M A R K E R S W I T H
QUANTIFIED FIBROSIS LEVELS OF NON-NAFLD, NAFLD, AND
NASH LIVER SAMPLES.
S. Stoddard1,2, Z. D. Goodman3, A.
2
1,2
1
Birerdinc & A. Baranova , School of Systems Biology, College of
Science, George Mason University Fairfax, VA, 2Center for the Study
of Chronic Metabolic Diseases, George Mason University, Falls
Church, VA, 3Inova Health System, Falls Church, VA.
Global
prevalence of nonalcoholic fatty liver disease (NAFLD) is currently at
25%, and is expected to increase as a major public health concern due
to the current worldwide obesity epidemic. The spectrum of NAFLD
includes nonalcoholic steatohepatitis (NASH) and steatohepatitic
hepatocellular carcinoma (SH-HCC). Not all patients with NAFLD
progress to NASH, and the diagnosis and grading of NAFLD/NASH is
dependent on the “gold standard” of invasive liver biopsy. Molecular
mechanisms behind the development and progression of this disease are
poorly understood, and this study attempts to correlate serum
biomarkers and adipocyte gene expression with quantified fibrotic liver
changes in NAFLD patients. Liver biopsies from obese non-NAFLD,
NAFLD, and NASH patients were analyzed via computerized
morphometry to quantify levels of steatosis and fibrosis. Preliminary
results of immunoassays on serum samples indicate a negative
correlation of INF-γ (p<0.05), IL-4 p<0.05), and G-CSF (p<0.01) with
percent collagen of liver biopsies. qPCR of adipose tissue will also be
performed for further understanding of this tissue as a driver of the
disease process. Correlation of serum biomarker levels with amount of
fibrosis as determined by computerized morphometry will be analyzed
to assess potential biomarkers for use as a diagnostic and/or prognostic
tool.
UNDERSTANDING OMICS PROFILING EXPRESSION BY USING
DISTANCE-BASED ANALYSIS AND NETWORK BIOLOGY. T.
Cui, J. R. Hamre & A. V. Baranova, School of Systems Biology,
George Mason University, Manassas VA. 20110. With large amount of
Omics data being generated every day, it's important to link the omics
profiling expression to patients who have varying degrees of disorder.
In this study, we propose a novel approach integrating distanced-based
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analysis and network biology to analyze transcriptomics and
proteomics data. We used several datasets including mRNA-Seq,
miRNA-Seq and proteomics datasets with different disease states from
GEO, TCGA and our collaborator at NIH. Samples from each group
were clustered close to the attractor that defines their corresponding
space center by global distances. The invasive breast carcinoma
mRNA-Seq dataset from TCGA showed a substantially separation
between normal/cancer samples. Additionally, the comparison between
colon adenocarcinoma miRNA-Seq and mRNA-Seq plot showed a
better separation between different disease states from the former,
which suggests the holistic miRNA landscape has superior predictive
power and can be used as a better diagnostic and prediction tool for
reflecting pathophysiological states of human tumors. Lastly, we
applied our model to a HDL proteomics dataset that is from 101
patients who have varying degrees of cardiovascular disease. We were
able to find four key proteins that may responsible for the disease
severity. In conclusion, using the measurement of Pearson’s holistic
distances together with network biology analysis, we demonstrated that
the omics profiling can be used to reflect sample’s regulatory
landscapes of overall gene/protein expression signatures, and help us
understand the role of diseased-associated genes/proteins in the
complex system.
NFAT5 IS DIFFERENTIALLY REGULATED IN THE BRAIN AND
BLADDER OF RATS FED A 4% NACL, 8% NACL, AND 64%
FRUCTOSE DIET. K. M. Ferguson, J. V. B. Fernandez & J. A.
Halterman, Dept. of Biology, Eastern Mennonite University,
Harrisonburg VA 22802. This research investigates the effects of a 4%
NaCl, 8% NaCl, 64% fructose, and control diet on the expression of
Nuclear Factor of Activated T-Cells 5 (NFAT5) in rat tissues. In human
health, diets low in salt lower the risk of cardiovascular disorders and
diets low in fructose lower the risk of metabolic disorders. However,
“low in salt/fructose” is a relative term because studies have
demonstrated individual differential responses to the same diets. In this
study, the effects of salt/fructose diets on the expression of NFAT5 were
examined in the bladder and brain of Sprague Dawley rats. This was
done by purifying and quantifying RNA, creating cDNA, and
quantifying NFAT5 expression by real-time PCR. The bladder tissue
showed decreased expression of NFAT5 following consumption of an
8% salt and 64% fructose diet. The brain tissue showed NFAT5
expression is increased following consumption of a 4% salt diet. These
results suggest that NFAT5 is differentially regulated in various tissues
of the body in response to dietary changes. Further inquiry into the
expression of NFAT5 in other tissues is needed in order to obtain a
comprehensive understanding of NFAT5 regulation in the body.
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Funding source: The Thomas F. and Kate Miller Jeffress Memorial
Trust, Bank of America, Trustee.
EXPLORING PHARMACOLOGICAL AND BEHAVIORAL
MECHANISMS INVOLVED IN ALCOHOL DEPENDENCE
DURING ADOLESCENCE. Rabha M. Younis1,2 & Imad Damaj2,
1Dept. of Microbiology & Genetics, 2Dept. of Pharmacology &
Toxicology, Virginia Commonwealth University, Richmond, VA,
23219. Alcoholism is a serious illness that is marked by uncontrollable
drinking and physical dependence to alcohol. Long-term alcoholism
has been linked to many health concerns such as cirrhosis of the liver
and cardiovascular disease. Alcohol is one of the most commonly used
drugs among adolescent populations. Given that adolescence is a
unique developmental stage during which alcohol has long-term effects
on future drug-taking behavior; it is essential to understand how early
exposure to alcohol during adolescent may affect the abuse liability of
the drug later in life. Our studies focus on identifying behavioral
mechanisms involved in alcohol dependence during adolescence by
using well-established mouse models of alcohol drinking. We
hypothesis that exposure to alcohol during early adolescence will
increase alcohol intake later in adulthood. We investigated the impact
of alcohol drinking in male and female early adolescent C57BL/6J
mice using the Drinking in the Dark (DID) model. Our results showed
that exposure to alcohol during early adolescence enhanced ethanol
intake later in adulthood in the DID paradigm. Our data illustrates that
enhanced alcohol intake are affected by the duration and age of
exposure. In addition, we conducted behavioral studies to elucidate the
mechanisms underlining the relationship between adolescent ethanol
exposures and enhance alcohol intake in adult mice. Our results showed
that ethanol exposure during adolescence altered the aversive state and
enhanced the rewarding properties of ethanol later in adulthood.
A FORMAL EXAMINATION OF TIMING OF HEART SOUNDS
RELATIVE TO ECG EVENTS IN COLLEGE STUDENTS. Harold J.
Grau & Michaela Miller, Dept. of Molecular Biol. & Chem.,
Christopher Newport Univ., Newport News, VA 23606. During each
cardiac cycle, the first heart sound (S1) is produced after the ventricle
begins contracting (enters systole), the pressure from which causes the
atrioventricular valve to slam shut. Once the ventricle begins relaxing
(ends systole), the semilunar valves close, creating the second heart
sound (S2). We recorded electrocardiograms (ECGs) and heart sounds
from 29 female (n=17) and male (n=12) college students (all between
the ages of 20 – 22 years of age) to see if there were any patterns to
variations in the timing of these heart sounds relative to the beginning
of systole (the peak R wave on the ECG) and end of systole (peak T
wave on the ECG). We also looked at other parameters such as heart
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rate, height, weight, and Basal Metabolic Index (BMI) to see if any
correlations occurred. There were no significant differences between
males and females (although there were differences in the distribution
of both heart sound delays). The timing of the heart sounds did not
correlate with each other, nor with heart rate, but did show a significant
(S1: P<0.01, S2: P<0.05) correlation to the BMI. Heart rate and BMI
did not correlate, but heart rate did correlate inversely (P<0.05) with
the interval between S1 and S2, which was also inversely correlated
significantly with the S1 delay (P<0.01) and with heart rate (P<0.05).
A longer S1 delay means that the ventricle takes longer to reach the
valve-closure pressure; a longer S2 delay indicates a longer period for
the ventricular pressure to fall below aortic pressure. The fact that
these are positively correlated with BMI suggests a possible health link
that merits further investigation.
EFFECTS OF METHYLENE BLUE ON THE ONSET AND
PROGRESSION OF BEHAVIORAL DEFICITS IN A TRANSGENIC
MOUSE MODEL OF ALZHEIMER’S DISEASE. H. J. Grau, S. E.
Fink, Q. E. Pace, B. C. Genovese, N. Khan, E. Croushore, K.
Whitcomb, R. A. Schendzielos, D. A. Mitrano & L. S. Webb, Dept. of
Molecular Biol. & Chem., Christopher Newport Univ., Newport News,
VA 23606.
Alzheimer Disease (AD) is a degenerative form of
dementia that is associated with the accumulation of neurofibrillary
tangles (tau protein) and amyloid=beta (AB) plaque formation.
Methylene blue (MB) has been FDA approved for reducing protein
aggregations in AD and other diseases. In this study, we used a triple
transgenic mouse model of AD (3xTg-AD) to assess any effects of MB
on the formation of these protein tangles and deposits development
(reported elsewhere) and on spatial learning and memory tasks
(reported here), by comparing mice given weekly intraperitoneal
injections of MB with those given saline injections (controls) . We
used the Morris Water Maze (MWM) to test for spatial learning and
memory on mice at 3, 4.5, 6, 7.5, 9, 12, 15, and 18 months of age; mice
were given 5 days of training (with platform), and then tested (no
platform) on day 6. The completed study will have 12 mice for each
treatment at each age end-point; the data reported here include results
from about half of that total. While the results to date are not
conclusive, mice at 6 and 7.5 months of age did perform better at the
MWM training (spatial learning) than their saline counterparts. On the
test day, which assesses spatial memory, MB treated mice did better at
3, 6, and 15 months of age. Differences between the groups should
become more evident once the data are complete.
NEUROPATHOLOGICAL EFFECTS OF METHYLENE BLUE ON
THE ONSET AND PROGRESSION OF ALZHEIMER’S DISEASE
IN A TRANSGENIC MOUSE MODEL. R. A. Schendzielos1, S. E.
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Fink1,2, Q. E. Pace1, N. Kahn2, B. C. Genovese1, E. Croushore2, K.
Witcomb1, D. Mitrano1,2, L. S. Webb1,2, & H. J. Grau1,2, 1Dept. of
Molecular Biology & Chemistry and 2Program in Neuroscience,
Christopher Newport University, Newport News VA 23606.
Alzheimer’s disease (AD) is a neurodegenerative disease that has been
shown to cause neurological changes in the brain, including the
development of both amyloid-beta (Αβ) plaques and neurofibrillary
(tau) tangles, as well as impaired cognitive functioning. Past studies
have shown that Methylene blue (MB), an FDA approved compound,
can reduce the formation of protein aggregates in AD and other
diseases. In this study, the 3xTg-AD mouse model, which contains the
human transgenes PS1m146V, APPSwe, and Taup301L, was used to further
explore the effect that MB has on the development of AD, specifically
on the accumulation of the Αβ plaques and tau tangles. Weekly
intraperitoneal injections of either MB (10 mg/kg) or 0.9% saline were
given, starting at 4 weeks and continuing until either 3, 4.5, 6, 7.5, 9,
12, or 15 months of age.
At these endpoints, the mice were
transcardially perfused with 4% paraformaldehyde/0.1%
glutaraldehyde, and the brains were removed and fixed for 72 hours in
4% paraformaldehyde and then cut with a vibrating microtome at
60µm. The tissue samples were stained with the clone 6E10 mouse
monoclonal antibody for Αβ plaques and with the p-tau rabbit antibody
for the tau tangles. Preliminary qualitative observations of the tissues
suggest that the MB-treated mouse brains had less Αβ and tau
accumulation; future work will incorporate quantitative analyses.
ROLE OF VAV2 IN PODOCYTE INFLAMMASOME ACTIVATION
A N D G L O M E R U L A R I N J U RY D U R I N G H Y P E R HOMOCYSTEINEMIA. S. M. Conley1, Z. Chen1, M. Xia1, T. W.
Gehr2, K. M. Boini1,2 & P.L. Li1, 1Dept. of Pharmacology &
Toxicology, 2Division of Nephrology, Internal Medicine, Virginia
Commonwealth University, School of Medicine, Richmond, VA.
Recently, our lab has reported that Vav2, a member of the guanine
nucleotide exchange factor (GEF) family contributes to the activation
of NADPH oxidase (NOX) in a membrane lipid signaling platform in
response to elevated levels of homocysteine (Hcys). However, it
remains unknown whether Vav2-mediated NOX activation is able to
trigger the NLRP3 inflammasome in podocytes and thereby lead to
podocyte dysfunction and glomerular injury associated with
hyperhomocysteinemia (hHcys). In our experiments, murine podocytes
were pretreated with either a Rac-1 inhibitor, NSC23766 or Vav2
activator, uridine triphosphate (UTP) and then stimulated with Hcys for
24 hours. Confocal microscopic analysis showed that treatment with
UTP increased the colocalization of inflammasome proteins NLRP3
with ASC or with caspase-1, suggesting inflammasome formation.
However, pretreatment of podocytes with NSC23766 blocked Hcys-
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induced inflammasome formation. Similar to Hcys, Vav2 activator,
UTP increased caspase-1 activation and consequent IL-1β production in
podocytes. However, attenuated caspase-1 activation and lower
IL-1βlevels were observed when podocytes were treated with
NSC23766. Our results suggest that Vav2 is a key signaling molecule
in mediating Hcys-induced podocyte inflammasome formation and
activation and consequent podocyte dysfunction and glomerular injury.
N I C O T I N E P R E V E N T S C H E M O T H E R A P Y- I N D U C E D
PERIPHERAL NEUROPATHY IN VIVO, AND FAILS TO
STIMULATE THE GROWTH OF LUNG CANCER CELLS OR
INTERFERE WITH THE EFFECTIVENESS OF CHEMOTHERAPY
IN VITRO. S. L. Kyte1, W. Toma1, M. I. Damaj1, X. Fang2 & D.A.
Gewirtz1, 1Dept. of Pharmacology & Toxicology and 2Dept. of
Biochemistry & Molecular Biology, Virginia Commonwealth
University, Richmond, VA 23298.
Chemotherapy has played a
significant role in the treatment and survival of cancer patients.
However, its use can lead to long-term symptoms of drug toxicity,
including chemotherapy-induced peripheral neuropathy (CIPN), a
result of peripheral nerve fiber dysfunction or degeneration. Paclitaxel
(Taxol), a taxane commonly used to treat breast, lung, and ovarian
cancers, has been found to cause CIPN in 59 to 78% of patients. There
is currently no effective preventative or therapeutic treatment for this
side effect. Our studies revealed that the nicotinic acetylcholine
receptor (nAChR) agonist, nicotine, is capable of reversing and
preventing the development of paclitaxel-induced CIPN in vivo, and
does not interfere with the cytotoxic properties of paclitaxel in vitro.
The use of von Frey filaments revealed that nicotine dose-dependently
reverses and prevents paclitaxel-induced mechanical allodynia. The in
vitro studies showed that nicotine fails to significantly stimulate growth
of A549, H460, Lewis lung carcinoma, or human explant lung cancer
cells. Most importantly, paclitaxel-induced H460 growth inhibition was
not significantly attenuated by nicotine. Moreover, nicotine failed to
alter the sub-G1 DNA content of paclitaxel-treated A549 cells. These
findings suggest that nAChRs may be promising drug targets for the
prevention and treatment of CIPN.
DOWNREGULATION OF MYELIN GENE EXPRESSION IN THE
ENTORHINAL CORTEX OF FINGOLIMOD TREATED MICE.
Jessica L. Jurmain & Michael F. Miles, Dept. of Pharmacology &
Toxicology, Virginia Commonwealth Univ., Richmond, Virginia,
23298. Studies in human and mouse models of alcoholism suggest a
role for myelin in the development of alcohol use disorders (AUDs)
and their associated pathologies. Myelin genes are downregulated in
the frontal cortex of alcohol dependent patients and in mouse models of
AUD. Studies in C57BL/6J and DBA/2J mice show correlations
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between basal myelin gene expression and behavioral responses to
acute ethanol exposure. Fingolimod (FTY720) is an FDA approved
drug for the treatment of relapsing multiple sclerosis. Literature reports
on FTY720 suggest a direct role for its receptor in demyelination and
remyelination. The significant overlap of genes regulated in
hippocampus of FTY720-treated immune-deficient mice with an
ethanol responsive gene set from our laboratory included several
myelin genes. This may suggest a common mechanism between the
effects of FTY720 and chronic ethanol treatment on myelin gene
expression that may be useful in elucidating a treatment for the myelinrelated pathologies associated with ethanol use. Using qRT-PCR we
examined the effects of oral FTY720 on myelin gene expression in
ethanol-naïve mice. There were no significant changes in myelin gene
expression in medial prefrontal cortex, caudate putamen, or nucleus
accumbens. Two myelin genes, Mbp and Plp, were significantly
downregulated in the entorhinal cortex of FTY720 treated mice, and
this downregulation was strongly correlated with the downregulation of
NFκB and Tlr4 expression. This suggests that FTY720 may aid in
elucidating a mechanism for demyelination associated with chronic
ethanol use.
MISSENSE MUTATIONS IN GONADOTROPIN-RELEASING
HORMONE RECEPTOR GENE IN PATIENTS WITH NORMOSMIC
IDIOPTHIC HYPOGONADOTROPIC HYPOGONADISM. N. V.
Zernov1, M. Y. Skoblov1,2, A. V. Baranova1,2,3,4 & K. Y. Boyarsky5,
1Federal State Budgetary Institution Research Centre for Medical
Genetics, Moscow, 115478, Russia, 2The Moscow Institute of Physics
& Technology, Dolgoprudny, Moscow Region, 141700, Russia, 3Center
for the Study of Chronic Metabolic Diseases, School of Systems
Biology, College of Science, George Mason University, Manassas, VA,
USA. 4Atlas Biomed Group, Moscow, 123317, Russia and 5Center of
Human Reproduction "Genesis", Department of Obstetrics and
Gynecology, State Pediatric Medical University, St.-Petersburg,
194100, Russia. Isolated hypogonadotropic hypogonadism (IHH) is a
rare genetic disease occurring in about 1-10 cases per 100,000 births. In
only 40% of these patients is the sense of smell is unchanged. This
normosmic IHH (nIHH) is due to a failure of gonadotropin-releasing
hormone (GnRH) pulsatile secretion in hypothalamus or its action in
pituitary. In nIHH patients, mutations are identified in genes GnRH1,
GnRHR, KISS1, KISS1R, TAC3 and TAC3R. We present our
observations of two non-consanguineous Russian female patients
diagnosed with nIHH. Prior to referral to fertility clinic, each patient
underwent about 10 years of hormone replacement therapy. Treatment
was successful in both patients who delivered phenotypically healthy
offspring. Direct sequencing of GnRHR gene identified homozygous
mutation c.416G>A in one patient and compound heterozygous c.
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416G>A/c.806C>T in another patient. To our knowledge, this is the
first observation of successful pregnancy of patients lacking GnRHR
function.
HAS THE ERADICATION OF THE POLIO VIRUS CONTRIBUTED
TO THE RISE IN SOLID TUMOR CASES IN RECENT YEARS? K.
Gwilliam1, A. Baranova1,2 & A. Birerdinc1,2, 1Center for Study of
Chronic Metabolic Disease, College of Science, George Mason
University, Fairfax, VA 22030 and 2Betty and Guy Beatty Center for
Integrated Research, INOVA Health System, Falls Church, VA 22042.
A genetically altered version of the polio virus is being used in a Phase
I study to treat glioblastioma multiforme (GBM) at the Preston Robert
Tisch Brain Tumor Center at Duke University by Dr. Gromeier and his
team. The genetically engineered poliovirus, PVS-RIPO, infects cells
that have poliovirus receptors yet is disabled from replicating in
normal, healthy cells. This raises the question of why and how polio
virus can target glioblastoma cells and its evolutionary origins. This
study uses publicly available databases, including the World Health
Organization, to assess the administration of the inactivated and oral
polio vaccine and the correlation incidence of polio and solid tumors
reported on a global scale. Out of 69 countries studied, from five WHO
regions, most displayed a decline in the incidence of poliomyelitis from
1988 onward. Many of the 69 countries also showed an increased
number of cancer cases between 1983 to 2007. A multivariate analysis
will be performed to determine if there is a correlation between the
eradication of polio in the human population and the rise in solid
tumors. Outcomes could reveal the polio virus' ability to regulate solid
tumors as well as possible influences that vaccination may have had on
this regulation. This information could assist in better administering the
polio virus for the treatment of solid tumors, such as GBM, as well as
provide valuable mechanistic and evolutionary insight into the coevolution of the polio virus and humans.
EPIGENETICS IN THE ETIOLOGY OF CHRONIC DISEASES. K.
Y. Jeong, A. Birerdinc & A. Baranova, Dept. of Biology, George Mason
University, Fairfax VA 22030 and Betty and Guy Beatty Center for
Integrated Research, Inova Health System, Falls Church VA 22042.
Several recent lines of research have shown that in addition to a
genetically predisposed profile, certain epigenetic factors play an
important role in both the development and progression of certain
chronic diseases such as NAFLD. Particularly for diseases under the
umbrella of Metabolic Syndrome, it has been demonstrated that
epigenetic as well as genetic factors play a crucial role in both the
presence and severity of these comorbidities. This article focused on
incorporating the epigenetic regulations found with the etiological
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pathways of chronic diseases. A systematic review was performed to
assess the work done to date. The two main investigated areas inflicted
by Metabolic Syndrome include the heart and the liver. Results found
that the accumulation of visceral fat increases expression of lipase
genes in the liver, leads to greater FFA mobilization and results in
hyperlipidemia linked with Steatosis and cardiovascular diseases.
Recruitment of cytokines released by adipocytes may be linked to
increased DNA methylation of glucokinase gene and hypomethylation
of hepatic cell cycle inhibitor Cdkn1a, which led to decreased and
increased expression, respectively, and contribute to NAFLD. The
subsequent review paper will aim to summarize and consolidate the
relationship between the epigenetic and genetic contributions to chronic
diseases under the umbrella of Metabolic Syndrome.
LIPID PROFILING IN CARDIOVASCULAR RISKS.
S.
Srivangipuram1,3, T. Cui2, J. Hamre2, B. Veytsman2, A. Birerdinc2,3 &
A. Baranova1,2,3, 1College of Science, George Mason Univ., Fairfax VA
22030, 2School of Systems Biology, George Mason Univ., Manassas
20110, 3Center for Study of Chronic Metabolic Diseases, George
Mason Univ., Falls Church., VA., Inova Health System, Falls Church.,
VA 22042. Different classes of High-density lipoproteins transport
cholesterol in blood and their inverse correlation with cardiovascular
disease (CVD) is well known. It is believed that HDL facilitates the
removal of excess cholesterol from peripheral tissues and delivers it to
the liver for excretion. Mass spectrometry was employed to identify
187 proteins and the amount of given protein detected in blood was
collected from 101 patients who have varying levels of cardiovascular
disease as measured by CT angiography. The HDL proteomics data was
displayed as a weighted spectrum count. The statistical software “R”
was used to perform descriptive and inferential statistics on the data. To
see if the proteins are expressed differently in diseased samples, a
preliminary analysis was conducted by comparing the median distance
of the counts to the normal space center. Since the mild severity group
was closer to the normal, these two groups were combined for distance
based analysis. There was not a gravitation of the counts towards a
specific severity. A Wilcoxon signed-rank test was used to test for
significant differences in protein expression among the different
severity groups (α=0.05). There was no significant difference in protein
expression between normal to moderate group, normal to severe, and
moderate to severe. The results suggest for further analysis by
separating the HDL binding proteins to see if they contribute to disease
severity.
FIBRONECTIN FIBRIL-ASSOCIATED GROWTH FACTORS IN
BREAST CANCER MICROENVIRONMENTS. Pascal Shukuru &
Lynne Elmore, Dept. of Pathology, Virginia Commonwealth University,
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Richmond VA 23298. Fibronectin (FN) is expressed in many breast
cancers (BC) and implicated in tumor progression. FN forms fibrils,
which can bind >40 soluble growth factors, many with pro-oncogenic
properties. Data indicate that breast adipose-derived mesenchymal
stem cells (bMSCs) promote BC cell growth and invasion as well
as the development of a FN-rich extracellular matrix. These
resident stem cells also express numerous FN binding growth
factors, including TGF-β1, and assembly FN fibrils, which bind
latent TGF-β1 binding protein 1 (LTBP1), an activator of TGF-β1.
These experimental data prompted us to investigate whether TGF-β1
and/or LTBP1 co-localize with FN fibrils in clinical specimens of BC.
Tissue microarrays were stained with Masson’s Trichrome to identify
fibrosis. Immunohistochemistry was performed to assess protein
expression levels and localization of TGF-β1 and LTBP-1. Many BC
specimens exhibited abundant FN-rich fibrotic stroma. TGF-β1 colocalized with FN fibrils in the extracellular matrix of many BC tissues,
while LTBP1 was expressed at variable levels in BC and stromal cells.
These data provide a foundation for testing whether co-localization of
FN binding growth factors (or mediator of these growth factors) and
FN fibrils associate with severity of disease.
ABUSE-RELATED EFFECTS OF GABAA RECEPTOR POSITIVE
ALLOSTERIC MODULATORS IN AN ASSAY OF INTRACRANIAL
SELF-STIMULATION IN RATS. K.L. Schwienteck1, G. Li2, M. M.
Poe2, J. M. Cook2, M.L. Banks1 & S.S. Negus1, 1Dept. of
Pharmacology & Toxicology, Virginia Commonwealth University,
Richmond, VA, 23298 and 2Dept. of Chemistry & Biochemistry,
University of Wisconsin-Milwaukee, Milwaukee, WI, 53211.
GABAA receptor positive allosteric modulators (GABAA PAMs) are
used clinically but also have abuse liability. Novel GABAA PAMs have
been developed that vary in efficacy at, and selectively
for, GABAA receptor subtypes that contain α1, α2 or α3 subunits.
Intracranial self-stimulation (ICSS) is one preclinical procedure that
has been used to evaluate abuse potential of drugs. This study
compared effects on ICSS produced by diazepam (high-efficacy and
relatively non-selective), zolpidem (high-efficacy and selective
for GABA A receptors containing an α1 subunit), and the
compounds JY-XHe-053, XHe-II-053 and HZ-166 (intermediateefficacy with putative selectivity for GABAA receptors that contain α2/
α3 subunits). Adult, male Sprague-Dawley rats (n=17) were trained in
an ICSS procedure. Diazepam (0.1-10 mg/kg) and zolpidem (0.032-3.2
mg/kg) produced transient abuse-related effects at low doses. JYXHe-053 (3.2-32 mg/kg) and HZ-166 (3.2-32 mg/kg) produced
significant but weaker and less reliable effects, and XHe-II-053 (3.2-32
mg/kg) had no effect. These results are consistent with other evidence
for abuse potential of diazepam and zolpidem and also suggest that
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high efficacy and/or selectivity at α1 GABAA receptor subtypes
contributes to abuse-related effects of GABAA PAMs. Supported by
NIH grants R01-NS070715, R01-MH096463, and VCU School of
Medicine.
ANTI-INFLAMMATORY DIDOX AS A TREATMENT IN A NEW
PROGRESSIVE MODEL OF EAE. D. J. Adkins1, K. C. Clark2, M.
Joslyn2, G. H. DeVries2 & J. L. Dupree2, 1Thomas Nelson Community
College, Hampton VA, 23666 and 2Dept. of Anatomy & Neurobiology,
Virginia Commonwealth University, 23284. Multiple sclerosis is an
autoimmune inflammatory disease that presents with motor, sensory
and cognitive impairment. In this study we used a mouse model of MS,
known as experimental autoimmune encephalomyelitis (EAE), to
investigate the efficacy of a novel anti-inflammatory drug as a potential
treatment for progressive MS. We induced a progressive form of EAE
in four mice which were monitored daily as they developed the disease.
At peak disease stage, two animals were administered the novel drug,
known as didox, for five consecutive days. Based on previous
observations from our lab using a chronic model of EAE, we
hypothesized that 1) the mice at peak disease would lose specific
axonal domains known as axon initial segments (AIS) in the brain and
nodes of Ranvier in the spinal cord; 2) that microglia, the resident
immune cells of the central nervous system, would make contact with
AIS and nodes of Ranvier; and 3) that the didox treated mice would
exhibit recovery of their AIS and nodes of Ranvier. Consistent with our
hypothesis, we found that both AIS and nodes of Ranvier were reduced
and microglia contacted ~20% of all AIS and all nodes of Ranvier.
Lastly, we found a partial recovery of AIS and nodes of Ranvier in the
didox treated mice. We conclude that in this progressive EAE model,
didox treatment may facilitate the reclustering of proteins essential for
AIS and node of Ranvier function.
NETWORK ANALYSIS OF CHRONIC ETHANOL RESPONSIVE
GENE EXPRESSION IN PREFRONTAL CORTEX REVEALS
CONSERVED CHANGES ACROSS MOUSE AND MACAQUE.
M.L. Smith1, J.W. Bogenpohl1, C. Helms2, M.F. Lopez3, K.A. Grant2,
H.C. Becker3 and M.F. Miles1, 1Dept. of Pharmacology & Toxicology,
Virginia Commonwealth Univ., Richmond, VA 23298, 2Dept. of
Behavioral Neuroscience, Oregon Health & Science Univ., Portland,
OR 97239, and 3Dept. of Psychiatry, Medical University of South
Carolina, Charleston, SC 29425. Alcohol use disorder (AUD) is a
significant public health problem. Characteristic features include
craving, withdrawal, and increased consumption. Here we use two
animal models explore gene expression responses in the prefrontal
cortex (PFC). Ethanol's effect on PFC is of interest due to its role in
executive function. C57BL/6J mice were exposed to ethanol by chronic
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intermittent ethanol (CIE) with 2 bottle choice drinking. Rhesus
macaques were exposed to ethanol using schedule induced polydipsia
(SIP). Gene expression was measured using Affymetrix microarrays,
and expression data was analyzed using Weighted Gene Correlated
Network Analysis (WGCNA). With WGCNA, groups of genes
showing significantly correlated expression in both mice and monkeys
were identified. Gene Ontology analysis revealed that modules
represented known biological processes including neurotransmission,
myelination, mitochondrial respiration, and regulation of gene
expression. These results indicate a conserved gene expression
response to chronic ethanol exposure in mice and monkeys. These
consensus modules, therefore, reveal biological themes in the
conserved response to chronic ethanol exposure across species, and
may represent therapeutic targets to modulate the behavioral features of
AUD such as escalating ethanol consumption.
PACLITAXEL-INDUCED NEUROPATHY AND MECHANICAL
ALLODYNIA DO NOT CORRELATE WITH BEHAVIORAL
DEPRESSION IN RATS. Luke P. Legakis & S. Stevens Negus, Dept.
of Pharmacology & Toxicology, Virginia Commonwealth University,
Richmond, VA. Paclitaxel is a cancer chemotherapy drug with adverse
effects that include chemotherapy-induced peripheral neuropathy
(CIPN), neuropathic pain, and depression of mood and behavior. These
adverse effects can limit the clinical use of paclitaxel and reduce patient
well-being for decades.
Preclinical research on expression and
treatment of paclitaxel-induced neuropathic pain has relied almost
exclusively on hypersensitive reflex-withdrawal responses to
mechanical or thermal stimuli as the primary measure of “pain.” It is
unknown if paclitaxel can also produce signs of pain-depressed
behavior in animals. The objective of this study was to evaluate
paclitaxel effects on rates of positively reinforced operant responding in
rats as a measure of functional impairment and behavioral depression.
The specific aim was to test the hypothesis that regimens of paclitaxel
treatment sufficient to produce neuropathy and mechanical allodynia
would also depress rates of positively reinforced operant responding in
assays of intracranial self-stimulation (ICSS) and food-maintained
responding. Paclitaxel decreased rates of both ICSS and foodmaintained responding in some rats, but the magnitude of depression
was not statistically significant in analysis of group data. Moreover, in
analysis of individual data, the magnitude of depression in rates of
operant responding did not correlate with either IENF loss or decreases
in mechanical sensitivity threshold. These results suggest that
neuropathy and mechanical allodynia do not cause behavioral
depression and may have different mechanisms than behavioral
depression.
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ETHANOL REGULATION OF NDRG1 AND THE EFFECTS OF
PFC MODULATION OF NDRG1 ON DRINKING BEHAVIOR. G.
M. Harris, A. D. van der Vaart, S. O. Park & M. F. Miles, Dept. of
Pharmacology & Toxicology, Virginia Commonwealth University,
Richmond, VA 23298.
Multiple molecular, pathological and
neuroimaging studies show perturbation of myelin or myelin gene
expression in alcoholics. Prior microarray studies in our laboratory
found down-regulation of myelin-related genes in prefrontal cortex
(PFC) of human alcoholic post mortem tissue as well as regulation of
myelin genes by acute ethanol exposure in mouse PFC. A measure of
acute sensitivity to ethanol that is frequently used in animal behavioral
studies is the Loss of Righting Reflex (LORR) duration. Our laboratory
has implicated N-myc down-regulated gene 1 (Ndrg1) as a potential
candidate gene that modulates ethanol-induced changes in myelinrelated gene expression and acute sensitivity to ethanol. Analysis of
PFC expression data found that Ndrg1 expression was positively
correlated with ethanol intake across the BXD panel of mice and
demonstrated that the basal levels of Ndrg1 mRNA expression in the
PFC across seven different strains of mice was inversely correlated
with LORR duration time. PFC-specific knockdown of Ndrg1 mRNA
by stereotactic injection of lentivirus expressing Ndrg1-shRNA in B6
mice, caused increased ethanol LORR duration and decreased
preference for ethanol. While CNS Ndrg1 is thought to be expressed
mainly in oligodendrocytes, we have observed it co-localized within
neurons in the PFC. A detailed characterization of Ndrg1 regulation at
the mRNA and protein expression level following acute or chronic
ethanol in currently underway. Viral methods are also being developed
to up-regulate Ndrg1 expression in oligodendrocytes and pyramidal
neurons within the PFC.
EFFECTS OF CHRONIC AMPHETAMINE ON BEHAVIORAL AND
NEUROCHEMICAL EFFECTS OF COCAINE IN RATS. Amy R.
Johnson & S. Stevens Negus, Dept. of Pharmacology & Toxicology,
Virginia Commonwealth Univ., Richmond, VA.
Amphetamine
maintenance decreases cocaine use in preclinical studies and clinical
trials. The mechanisms underlying the anti-cocaine effects of
amphetamine are not well understood. This study evaluated abuserelated effects of cocaine on intracranial self-stimulation (ICSS) and on
nucleus accumbens dopamine and serotonin (NAc DA and 5HT) levels.
We hypothesized that amphetamine maintenance would decrease both
cocaine-induced ICSS facilitation and enhancement of NAc DA. Male
Sprague-Dawley rats were used for all studies. For ICSS, electrodes
were implanted in the medial forebrain bundle, and responding on a
lever produced pulses of electrical brain stimulation in a frequency-rate
ICSS procedure. Effects of cumulative cocaine doses (1-10 mg/kg IP)
were determined before and after 7-day treatment with saline, 0.1 or
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0.32 mg/kg/hr amphetamine delivered by a subcutaneous osmotic
minipump. For microdialysis, rats were implanted with cannulae
targeting the NAc, and dialysates were analyzed for concentrations of
DA and 5HT before and after 10 mg/kg IP cocaine. Cocaine facilitated
ICSS and increased NAc levels of both DA and 5HT. Amphetamine
maintenance facilitated ICSS throughout treatment and eliminated
cocaine-induced ICSS facilitation. Amphetamine maintenance also
increased basal DA concentration and eliminated cocaine-stimulated
increases in NAc DA without affecting basal 5HT concentration. These
results suggest that amphetamine maintenance decreases abuse-related
behavioral effects of cocaine by decreasing cocaine-induced increases
in mesolimbic DA. Supported by R01DA026946.
IMMUNOLOGICAL LANDSCAPE OF NSCLC: OPPORTUNITIES
FOR INTERVENTION? Se W. Jeong & Timothy N.J. Bullock, Dept.
of Pathology, University of Virginia, Charlottesville, VA 22908. Lung
cancer is the leading cause of annual cancer related mortality in the
United States. More than 150,000 people in the US will die from lung
cancer this year which will lead to roughly as many deaths as breast,
prostate, colon, and pancreatic cancers combined. Lung cancer is also
of global concern as tobacco use in developing countries has risen
significantly. Stage II and III non-small cell lung cancer (NSCLC)
patients often have a 5-year disease free survival of less than 50% even
after surgical resection and post-operative chemotherapy and a dismal
5% overall survival for patients with metastatic disease. Even with the
advent of PD-1/PDL-1 checkpoint blockade immunotherapies, only
about 20% of patients are responsive to the treatment. This limited
scope of success may be due to our lack of understanding the immune
landscape of NSCLCs. Therefore, we set out to characterize the
immune composition from surgical lung resections via flow cytometry.
We found that NSCLCs have a diverse set of checkpoint inhibitor and
co-stimulatory molecules expressed by T cells, including PD-1, TIM-3,
and TIGIT. Interestingly, even though PD-1 was elevated compared to a
normal donor, the expression level was lower than either breast or
melanoma tumor samples. In addition, regulatory T cell populations
have a profound presence in these lung tumors. These findings suggest
potential molecules as targets of interest for immunotherapy but also
the importance of recognizing the diversity of immune populations that
exist within a tumor.
EFFECTS OF TRAUMATIC BRAIN INJURY ON OXYCODONE
REINSTATEMENT AND PHYSICAL DEPENDENCE.
Neil B.
Varshneya & Katherine L. Nicholson, Dept. of Pharmacology &
Toxicology, Virginia Commonwealth University, Richmond, VA 23298.
Epidemiological data indicate that patients who experience a traumatic
brain injury (TBI) have an elevated risk of developing a substance use
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disorder (SUD), however the underlying neurobiological connections
remain unclear. We investigated the effects of TBI on the abuse-related
effects of oxycodone in preclinical models. Our evaluation utilized a
lateral fluid percussion injury of moderate severity in adult male
Sprague-Dawley rats. In the first aim, we tested the hypothesis that
moderate TBI increases the risk for relapse to an opioid use disorder as
measured by reinstatement of lever-pressing behavior following
extinction in an intravenous oxycodone self-administration procedure.
In the second aim, we tested the hypothesis that moderate TBI
increases physiological dependence to oxycodone as measured by
decreases in food-reinforced lever-pressing behavior and increases in
other withdrawal behaviors in both precipitated withdrawal and
spontaneous withdrawal. In reinstatement tests, non-injured subjects
reinstated responding under oxycodone-associated cue- and oxycodone
prime-induced conditions, however, brain-injured subjects did not
reinstate lever-pressing behavior under any conditions. In dependence
tests, brain-injured subjects showed no significant differences from
non-injured subjects in mean withdrawal scores or food-reinforced
lever-pressing behavior. Overall, these data suggest that brain-injured
patients with no significant pre-morbid history of opioid abuse have
lesser risk of relapse to opioid use disorders. Supported by Department
of Defense, W81XWH-11-1-0374.
ETHANOL REVERSAL OF OPIOID TOLERANCE IN MICE.
Joanna C. Jacob & William L. Dewey, Dept. of Pharmacology &
Toxicology, Virginia Commonwealth University, Richmond, VA 23298.
Prescription opioids are generously prescribed due to their highly
effective antinociceptive properties, however their use is limited by a
high abuse potential due to euphoric effects. Chronic opioid use,
whether for clinical or recreational purposes, is often coupled with the
use of other substances, such as ethanol. Dangerous drug interactions
are known to occur with opioids and ethanol, yet the mechanisms are
not understood. This led to the investigation and hypothesis that ethanol
reverses tolerance to at least some opioid effects, such as analgesia and
respiratory depression, ultimately leading to overdose and death. We
found a significant and dose-dependent reversal of morphine-induced
analgesic tolerance by ethanol, as measured by warm-water tail
withdrawal in Swiss Webster mice. Similar studies were carried out for
oxycodone and hydrocodone, where analgesic tolerance was developed
via chronic s.c. injections of an ED80 dose, and then altered by a single
i.p. injection of 1g/kg ethanol. The ED50 for oxycodone was
significantly shifted from 0.9 mg/kg (0.72 – 1.12) to 1.70 mg/kg (1.42
– 2.03) after repeated administration and returned to 1.02 mg/kg
(0.77-1.37) after 1 g/kg ethanol administration. Similarly, the ED50 for
hydrocodone was shifted from 3.92 mg/kg (3.26 – 4.71) to 9.01 mg/kg
(6.44 – 12.62) and returned to 4.73 mg/kg (3.51 – 6.38) after 1 g/kg
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ethanol administration. Together these data support the hypothesis that
ethanol reverses analgesic tolerance to opioid drugs in addition to
morphine, and could be working through the same mechanisms.
PROLIFERATIVE RECOVERY AND REVERSIBILITY OF
THERAPY-INDUCED SENESCENCE IN NON-SMALL CELL
LUNG CANCER.
Tareq Saleh & David A. Gewirtz, Virginia
Commonwealth Univ., Dept. of Pharmacology & Toxicology,
Richmond, VA. Lung cancer is the leading cause of cancer-related
death in both men and women in the United States. Most lung cancer
cases are diagnosed in advanced, inoperable stages and are treated with
chemoradiation; while chemoradiation is effective in suppressing tumor
progression, recurrence following treatment is not infrequent. The
involvement of autophagy, senescence and apoptosis in the actions of
etoposide, one of the primary drugs utilized in the treatment of nonsmall cell lung cancer (NSCLC), was studied in H460 NSCLC cells.
Exposure to etoposide resulted in growth arrest accompanied by the
induction of senescence, but minimal apoptosis. Growth arrest was
transient in that proliferative recovery was evident by day 7 post
exposure. Quantification of senescence over time based on C12FDG
staining and flow cytometry demonstrated that the reversal of growth
arrest coincided with a decline in the extent of senescence. To more
precisely define the source of the recovered cells, senescent and nonsenescent but growth arrested cells were separated by flow cytometry
based on their relative β-galactosidase expression and replated. Both
cell populations demonstrated the ability to re-emerge from the growtharrested state and recover proliferative capacity. These observations
suggest that senescence is ultimately a transient process in that at least
a subpopulation of tumor cells can and will recover proliferative
capacity. We propose that the reversibility of therapy-induced
senescence (TIS) might be developed as a model for studies of tumor
dormancy and disease recurrence.
MOLECULAR MODELLING AND VIRTUAL SCREENING OF
PLASMODIUM FALCIPARUM GLYCOGEN SYNTHASE KINASE 3
(pfGSK-3) FOR ATP NON-COMPETITIVE INHIBITORS. S. Obeng,
S. A. Zaidi, P. D. Mosier & Y. Zhang, Dept. of Medicinal Chemistry,
Virginia Commonwealth University, Richmond VA 23298-0540. The
purpose of this study was to screen for new lead compounds that are
ATP non-competitive pfGSK-3 selective inhibitors to treat malaria.
Since there is no crystal structure of pfGSK-3 available, a blast search
of the PDB database was carried out. The human glycogen synthase
kinase 3β (hGSK-3β) (PDB: 4ACC) was identified as the enzyme with
the highest homology to pfGSK-3 with a sequence identity and
similarity of 42.9% and 60.4% respectively. Using hGSK-3β as the
template, 100 models of pfGSK-3 were constructed using MOD9.14.
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The best model was selected by docking a known pfGSK-3 ATP noncompetitive inhibitor (manzamine) into a binding pocket comprising
residues Arg 96, Arg 180, Lys 205, and Tyr 216. The best model
obtained was used to carry out a virtual screening of the NCI and
ZINC-sigma aldrich libraries using UNITY. The hits obtained were
docked into the pfGSK-3 homology model using GOLD52 and the
scoring function CHEMPLP. Three compounds with CHEMPLP scores
of 111.07, 97.81, and 95.47 were identified as lead compounds.
NOVEL PHOTOAFFINITY PROBES FOR α-N-TERMINAL
WRITERS. B. D. Mackie1, S. L. Richardson2 & R. Huang1, 1Dept. of
Medicinal Chemistry and 2Dept. of Chemistry, Virginia Commonwealth
University, Richmond VA 23219. Protein α-N-terminus undergoes a
variety of modifications including methylation, acetylation,
myristoylation, and palmitoylation. It has been hypothesized that there
is dynamic interplay among those modifications, such as methylation
and acetylation. Methylation has recently demonstrated its important
role in regulating protein-DNA interactions, mitotic division and DNA
damage repair. Acetylation is involved in protein degradation,
localization, and complex formation. To explore these dynamic
modifications, we developed photoaffinity probes to profile enzymes
that are responsible for α-N-terminal modifications. We have
successfully synthesized a photoaffinity probe which contains three
main components: a recognition element, a photocrosslinker, and a
fluorescent tag. The recognition element is crucial for selectivity, the
photocrosslinker is needed to covalently bond the probe to the target
and the tag is necessary for fluorescence imaging. The photoaffinity
probe’s recognition element was derived from the N-terminus of
Retinoblastoma1 (RB1), a substrate of N-terminal methyltransferase 1
(NTMT1). Our results suggest that our probe exhibits in a dose
dependent, time dependent and competitive manner. Photoaffinity
labeling was competitively inhibited when NTMT1 was incubated with
the probe and varying concentrations of RB1-10. The RB1 probe also
selectively labeled NTMT1 when NTMT1 was spiked into a nuclear
extract cell line, verifying specificity of the probe for NTMT1. Lastly,
the probe was enzymatically methylated by NTMT1, giving further
validation that labeling is driven by recognition.
IMPROVING THE SIDE EFFECT PROFILE OF
ANTICOAGULANTS USING THROMBIN ALLOSTERISM. D. K.
Afosah1,2, S. Verespy2,3, R. Karuturi1,2, R.S. Boothelllo2 & U. R.
Desai1,2, 1Dept. of Medicinal Chemistry and 2Institute for Structural
Biology, Drug Discovery and Development, Virginia Commonwealth
University, Richmond VA 23219, and 3Dept. of Chemistry, Virginia
Commonwealth University, Richmond VA 23284. Thrombin is a serine
protease that occupies a central position in the coagulation cascade. Its
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key feature is the conversion of fibrinogen to fibrin, a key component
of blood clots. Currently, all thrombin inhibitors on the market inhibit
the protease fully resulting in increased risk of bleeding with their use.
We reasoned that it should be possible to develop partial inhibitors of
thrombin that allow reasonable proteolytic activity even at saturating
concentrations of the inhibitor. Based on our earlier work with sulfated
benzofuran dimers, which showed 75% inhibition at saturation
concentrations, we designed advanced analogs using computational
virtual screening. These analogs were synthesized and their biological
profile studied using biochemical assays. The results show that a
distinct group of analogs display inhibition efficacies of ~50-60% at
saturation in chromogenic substrate assay, whereas others exhibit
efficacies of ≥80%. Similar results were observed in the fibrinogen
assay suggesting that submaximal inhibition is maintained with
thrombin’s in vivo substrate. The results indicate that thrombin’s high
plasticity can be exploited to realize a clinically relevant homeostatic
inhibitor that resolves bleeding risk.
INTERPLAY BETWEEN ARTEMIS AND TDP1 IN SENSITIVITY
TO RADIOMIMETIC AGENTS. A. Kawale, K. Akopiants & L. F.
Povirk, Dept. of Pharmacology & Toxicology, Virginia Commonwealth
University, Richmond, VA 23298. DNA double-strand breaks (DSBs)
containing unligatable termini are potent cytotoxic lesions leading to
growth arrest or cell death. Artemis, which is associated with the NonHomologous End Joining (NHEJ) pathway, is the major end processing
nuclease that resolves unligatable termini, especially the 3′ blocks, by
nucleolytic trimming. Tyrosyl-DNA Phosphodiesterase 1 (TDP1) is an
enzyme which is biochemically competent in 3′-phosphoglycolate
processing. The purpose of this study is to investigate if TDP1 is an
end-processing enzyme involved in the NHEJ pathway. A cell line with
combined deficiency in Artemis and TDP1 was generated by infecting
Artemis-/- single mutants with a lentivirus expressing a TDP1 shRNA.
Positive clones were screened for maximum TDP1 knockdown which
was found to be around 14X. Clonogenic survival assays carried out on
shTDP1 & Artemis-/- single mutants and the Artemis-/-.shTDP1 double
mutants showed similar sensitivity to NCS and Calicheamicin. Thus,
surprisingly, these experiments suggest that TDP1 functions are
epistatic with Artemis in the NHEJ pathway for repair of DNA doublestrand breaks.
HYBRID MOLECULES AS TOOLS TO STUDY CLASSICAL 5HT2A RECEPTOR LIGANDS. U. H. Shah1, S. A. Gaitonde1, J. L.
Moreno2, J. Gonzalez-Maeso2, M. Dukat1 & R. A. Glennon1, 1Dept. of
Medicinal Chemistry, and 2Dept. of Physiology & Biophysics, Virginia
Commonwealth University, Richmond VA 23298. Serotonin-2A (5HT 2A ) receptor antagonists have therapeutic applications in
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schizophrenia and belong to diverse chemical classes. Current
pharmacophore models for 5-HT2A receptor antagonists suggest that
these agents might have multiple binding modes. Reported
pharmacophores include two aromatic/hydrophobic regions and a
protonated amine. Hybrid molecules (Ket/Ris and Ris/Ket) of two
known 5-HT2A antagonists, ketanserin (Ket) and risperidone (Ris),
were synthesized by our laboratory to study their binding modes.
Binding data showed that Ket/Ris (Ki = 0.96 nM) binds with 19-, 5- and
13- fold higher affinity than Ket, Ris and Ris/Ket, respectively. The
high affinities of Ris and Ket/Ris can be attributed to an additional
bifurcated interaction as shown in homology models of 5-HT2A
receptors, which is not possible with the benzoyl ring in Ket and Ris/
Ket. We synthesized deconstructed analogs of Ris and Ket to determine
which portions contribute to 5-HT2A receptor affinity and antagonism.
4-(4-Fluorobenzoyl) piperidine and FBIP, deconstructed analogs of Ket
and Ris, respectively, were found to be 5-HT2A receptor antagonists.
Therefore, we have successfully identified a new pharmacophore for 5HT2A receptor antagonists that consists of one aromatic region,
hydrogen bond acceptors, and a basic protonated amine. FBIM (Ki ca
12 nM), a deconstructed analog of Ris (Ki = 5 nM), was identified as a
new high-affinity 5-HT2A receptor antagonist. Published 5-HT2A
receptor antagonist models will now need to be completely revised.
THE TALE OF THREE TESTS: PARAXODICAL MODULATION
OF OXYCODONE-INDUCED ANTINOCICEPTION BY
LORCASERIN. Kumiko M. Lippold & William L. Dewey, Dept. of
Pharmacology & Toxicology, Virginia Commonwealth Univ.,
Richmond, VA, 23298. Prescription opioids are important therapeutic
agents for the treatment of pain that with chronic use, produce
tolerance, dependence, and in many cases, addiction. There is a need to
develop new approaches for minimizing the risk of opioid abuse and
reducing overdose-related deaths. The underlying neurobiological
mechanisms of these conditions suggest a modulatory role of the
serotonergic system in the pharmacological effects of opiates.
Lorcaserin is a selective agonist, at the serotonergic 5-HT2C receptor,
approved by the FDA for the treatment of obesity but recently
investigated as a potential treatment for drug abuse and dependence.
Preclinical studies have demonstrated the efficacy of lorcaserin to
reduce the abuse-related effects and dependence behaviors of opiates.
We evaluated lorcaserin in the acute effects of oxycodone using tests of
nociception and observed paradoxical modulation of the
antinociceptive effects of oxycodone, in a divergent manner, in models
of spinally-mediated and supraspinally-mediated thermal nociception.
Lorcaserin potentiated the antinociception produced by oxycodone in
the tail immersion test (a spinally-mediated reflex) and in the hot plate
assay (a test of supraspinally-mediated pain), there was an attenuation
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of the antinociceptive effects of oxycodone. Interestingly, lorcaserin
also suppressed stretching activity in mice that received an
intraperitoneal injection of acetic acid but when administered prior to
oxycodone, no significant effects were observed. These data suggest a
contrasting role of the 5-HT2C receptor in the effects elicited by
oxycodone in the brain, spinal cord, and viscera.
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